BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22519427)

  • 1. The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy.
    von Bubnoff D; Bieber T
    Allergy; 2012 Jun; 67(6):718-25. PubMed ID: 22519427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine-2,3-dioxygenase modulation of allergic immune responses.
    Le AV; Broide DH
    Curr Allergy Asthma Rep; 2006 Feb; 6(1):27-31. PubMed ID: 16476191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.
    Johnson BA; Baban B; Mellor AL
    Immunotherapy; 2009 Jul; 1(4):645-61. PubMed ID: 20161103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model.
    Taher YA; Piavaux BJ; Gras R; van Esch BC; Hofman GA; Bloksma N; Henricks PA; van Oosterhout AJ
    J Allergy Clin Immunol; 2008 Apr; 121(4):983-91.e2. PubMed ID: 18179817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling.
    Kawaguchi R; Shimokawa T; Umehara N; Nunomura S; Tanaka T; Ra C
    J Reprod Immunol; 2008 Apr; 77(2):117-25. PubMed ID: 17942160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy.
    Grohmann U; Volpi C; Fallarino F; Bozza S; Bianchi R; Vacca C; Orabona C; Belladonna ML; Ayroldi E; Nocentini G; Boon L; Bistoni F; Fioretti MC; Romani L; Riccardi C; Puccetti P
    Nat Med; 2007 May; 13(5):579-86. PubMed ID: 17417651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure.
    von Bubnoff D; Fimmers R; Bogdanow M; Matz H; Koch S; Bieber T
    Clin Exp Allergy; 2004 Jul; 34(7):1056-63. PubMed ID: 15248850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On watching the watchers: IDO and type I/II IFN.
    Puccetti P
    Eur J Immunol; 2007 Apr; 37(4):876-9. PubMed ID: 17393386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.
    Munn DH
    Curr Opin Immunol; 2006 Apr; 18(2):220-5. PubMed ID: 16460921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of indoleamine 2,3-dioxygenase in transplantation.
    Hainz U; Jürgens B; Heitger A
    Transpl Int; 2007 Feb; 20(2):118-27. PubMed ID: 17239019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer.
    Fotopoulou C; Sehouli J; Pschowski R; VON Haehling S; Domanska G; Braicu EI; Fusch G; Reinke P; Schefold JC
    Anticancer Res; 2011 Aug; 31(8):2629-35. PubMed ID: 21778315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation.
    Puccetti P; Grohmann U
    Nat Rev Immunol; 2007 Oct; 7(10):817-23. PubMed ID: 17767193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of indoleamine 2,3-dioxygenase on transplantation immunity].
    Duan X; Cui P; Jiang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):230-3. PubMed ID: 18365624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IDO in organ transplantation: promises and difficulties.
    Löb S; Königsrainer A
    Int Rev Immunol; 2009; 28(3-4):185-206. PubMed ID: 19811321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Opin Organ Transplant; 2008 Feb; 13(1):10-5. PubMed ID: 18660700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecules in focus: indoleamine 2,3-dioxygenase.
    King NJ; Thomas SR
    Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus.
    Romani L; Zelante T; De Luca A; Bozza S; Bonifazi P; Moretti S; D'Angelo C; Giovannini G; Bistoni F; Fallarino F; Puccetti P
    Med Mycol; 2009; 47 Suppl 1():S154-61. PubMed ID: 18608907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
    Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
    Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.